World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat

AbstractHelicobacter pylori-associated gastritis leads to the development of gastric cancer. Kyoto global consensus report onH. pylori gastritis recommendedH. pylori eradication therapy to prevent gastric cancer. To manageH. pylori infection, it is important to choose the appropriate regimen considering regional differences in resistance to clarithromycin and metronidazole. Quinolones and rifabutin-containing regimens are useful as third- and fourth-line rescue therapies.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research